L3VLUP
ProSign in

DMRA in the 13F filings

Damora Therapeutics Inc · CUSIP 36322Q206

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025
Quarter end
31 Mar 2026
the date the book describes
Filed
18 May 2026
latest of these filings; the earliest 12 May 2026
Managers listing it
14
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q4 2025 and Q1 2026; 1 listed it in both
Shares listed
18,247,473
combined, among listed positions
Reported value
$473m
combined, at the quarter end

Among the 91 comparable managers: 14 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +5,645,588.

Managers listing DMRA in Q1 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

14 of 14 holders

ActionFiling
Fidelity (FMR LLC)9,045,481$234munder 0.1%Added+8,806,60315 May 2026 (the filing on sec.gov)
Janus Henderson Group Ltd2,362,696$61munder 0.1%Added+2,360,95718 May 2026 (the filing on sec.gov)
Viking Global Investors LP2,311,082$60m0.17%Newnew15 May 2026 (the filing on sec.gov)
Balyasny Asset Management LLC1,448,000$38munder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Point72 Asset Management LP1,193,708$31munder 0.1%Added+1,084,70815 May 2026 (the filing on sec.gov)
Wellington Management Group LLP1,058,000$27munder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Millennium Management LLC471,646$12munder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Marshall Wace LLP169,818$4.4munder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Hudson Bay Capital Management LP76,338$2.0munder 0.1%Newnew13 May 2026 (the filing on sec.gov)
Brevan Howard Capital Management LP55,232$1.4munder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Squarepoint Ops LLC23,458$608kunder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Jane Street Group LLC11,420$296kunder 0.1%Newnew12 May 2026 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC10,824$280kunder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Susquehanna International Group LLP9,770$253kunder 0.1%Newnew15 May 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2025 to Q1 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (11)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q4 2025 to 2 in Q2 2026

Tracked managers listing it, at least.

0123Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
DMRA by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20251$40m32
Q1 20263$159m140
Q2 20262$119m810

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

DMRA and LLY →DMRA and JNJ →DMRA and VRTX →Choose a stock to compare with DMRA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own DMRA, latest filings →Back to the 13F Explorer →